Formononetin (4 g) was dissolved into NaOH (50 ml, 5%). Diethyl sulfate (6 ml) was added dropwise to the solution with vigorous stirring. The mixture was stirred at room temperature for 3h and some precipitation appeared. The precipitate was filtered and washed with water until the pH of the filtrate was 7t oo btain monoethoxyformononetin (4'-methoxy-7-ethoxylisoflavone, 3.5 g). Then, monoethoxyformononetin (2 g) was slowly added to the concentrated sulfuric acid (8 ml), The mixture was stirred at room temperature for 1hand poured into asaturated NaCl solution (60 ml) and awhite precipitate formed. This precipitate was collected by filtration and washed with saturated NaCl solution until the pH value of the filtrate was 7. Finally, the precipitate was recrystallized from water to afford sodium monoethoxyformononetin-3'-sulfonate (yield, 80.40 %). Sodium monoethoxyformononetin-3'-sulfonate (1 g) was dissolved in water (10 ml), then mixed with saturated ZnSO 4 ·7 H 2 Os olution (5 ml). The title compound were obtained from water after 24 h. It is aw atersoluble derivative of formononetin, with potential medical applications. Crystals of the title compound suitable for single crystal X-ray analysis were recrystallized from water after two weeks at room temperature.
Discussion
Formononetin (4'-methoxy-7-hydroxyisoflavone), as an effective principals of isoflavone, display awide range of biological activities, such as antioxidant [1] , inhibiting cardiovascular disease [2, 3] and balancing women's hormone [4] . However, the biological utilization rate is low and the dose is high for its poor solubility, which limit its wide applications. Thus, it is necessary to synthesize awater soluble derivative of formononetin in order to study its possible biological effects. The crystal structure of the title compound is composed of acomplex cation [Zn(H 2 O) 6 ] 2+ ,t wo monoethoxyformononetin-3'-sulfonate anion C 18 H 15 O 4 SO 3 -and four lattice water molecules. Zn (II) lies on an inversion centre and is coordinated by six water molecules which forms as lightly distorted octahedral complex cation, in which the average bond length of Zn-O is 2.089 Å. The dihedral angle between ring A (C10-C15) and ring C (C8-C10/O9/C15-C16) is 4.1(2)°, and that of the benzopyrane moiety (C8-C16/O9) and ring B (C2-C7) is 9.6(2)°. The sulfo-group (-SO 3)o fthe isoflvone skeletons, the four lattice water molecules and the six coordinated water molecules are linked by eight kinds of hydrogen bonds among them. These hydrogen bonds not only link the isoflavone skeletons, coordinated water molecules and lattice water molecules into together, but also play very important roles in the formation, stability and crystallization of the title compound. The isoflavone skeletons arrange in antiparallel fashion and the aromatic F-tape and T-tape p-p stacking interactions exist together in harmony between them, consisting of acolumn along [010] . Fistly, two kinds of aromatic F-tape stacking interactions exist in the crystal structure of title compound. On one hand, the rings C of two neighbour isoflavone skeletons stack with each other with d(CgC-CgC * )=3.712(3) Å,where Cg and Cg * are the center of ring C of the neighboring isoflavone skeleton at (x,y,z) and (2-x,2-y,2-z), respectively. The interplanar spacing measures to 3.5497 Å.Onthe other hand, the ring AC of isoflavone skeleton at (x,y,z)isnearly paralleled to the ring B at (2-x,1-y,2-z), the dihedral angle between them being 9.6°. 2+ and the anion sulfonate C 18H15O4SO3 -lead to the moieties into supramolecule with athree-dimensional structure. 
